We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Therapy for Restless Legs Syndrome

David H. Neustadt, MD, MACR
Arch Intern Med. 1996;156(20):2386. doi:10.1001/archinte.1996.00440190144016.
Text Size: A A A
Published online


I read with interest O'Keeffe's1 excellent review article on restless legs syndrome (RLS), an often neglected and overlooked nonarticular rheumatic condition. It should be emphasized that although periodic movements of sleep is present in approximately 10% of the normal population, almost all patients who have RLS have periodic movements of sleep as well.2

I agree with O'Keeffe's therapeutic recommendations, especially that levodopa is effective; however, in my experience, troublesome side effects are not uncommon during extended therapy. On the other hand, a useful pharmacological approach for the treatment of RLS, which is not described by O'Keeffe, is the use of orphenadrine citrate. Although no randomized controlled trials have been reported, observational studies in my experience and in that of others have shown orphenadrine to be extremely effective and safe in controlling the symptoms of RLS and periodic movments of sleep.3-5 Initial dosage should be one 100-mg tablet


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.